Headlines from across medwireNews
27-04-2017 | Rheumatology | News | Article
Adalimumab shows promise in JIA-associated uveitis
Trial results published in The New England Journal of Medicine suggest that adding adalimumab to methotrexate treatment enhances the control of inflammation and reduces the rate of treatment failure among children and adolescents with juvenile idiopathic arthritis-associated uveitis.
Beyond the news
medwireNews brings you news and conference reports from the ESMO 2016 Congress, held in Copenhagen, Denmark.
Click through to read the full reports of the latest research.
Highlights from the 1st conference of the European Academy of Neurology in Berlin, Germany.
Click through to read research news from the conference.
medwireNews is an established provider of authoritative, timely and independent medical news. We value your feedback and encourage you to contact us to make medwireNews.com your preferred medical news resource.
Asthma attack_woman/© skynesher / Getty Images / iStock, Salmon_avocado_nuts/© Yulia Furman / Fotolia, migraine_headache3, lung_cancer, ESMO 2016 flags_enhanced/© Lynda Williams, Children with medical team/© Christopher Futcher, Brandenburg Gate/© Nikada/iStock, Lucy Piper, Lynda Williams, Eleanor McDermid, Shreeya Nanda, Claire Barnard, Alison Chapman, Kamran Ahmad